KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Inventory (2017 - 2025)

Guardant Health (GH) has disclosed Change in Inventory for 9 consecutive years, with -$4.6 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 280.07% to -$4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.8 million through Dec 2025, up 61.93% year-over-year, with the annual reading at $14.8 million for FY2025, 61.93% up from the prior year.
  • Change in Inventory hit -$4.6 million in Q4 2025 for Guardant Health, down from $6.4 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $23.3 million in Q2 2022 to a low of -$15.1 million in Q4 2023.
  • Historically, Change in Inventory has averaged $3.2 million across 5 years, with a median of $4.7 million in 2024.
  • Biggest YoY gain for Change in Inventory was 1077.37% in 2022; the steepest drop was 292.94% in 2022.
  • Year by year, Change in Inventory stood at $5.9 million in 2021, then plummeted by 292.94% to -$11.4 million in 2022, then tumbled by 31.76% to -$15.1 million in 2023, then soared by 91.95% to -$1.2 million in 2024, then plummeted by 280.07% to -$4.6 million in 2025.
  • Business Quant data shows Change in Inventory for GH at -$4.6 million in Q4 2025, $6.4 million in Q3 2025, and $6.8 million in Q2 2025.